li

JAMA Neurology : Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke

Interview with Adrian F. Hernandez, MD, MHS, author of Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic Stroke: Findings From the Patient-Centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research (PROSPER) Study








li

JAMA Cardiology : Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels

Interview with Kausik K. Ray, MD, author of Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial, and Maarten JG. Leening, MD, PhD, author of Safety and Tolerability of Sustained Lipid-Lowering Therapy: Trial Data and Public Perception in a World Where Vaccines and Statins Are About to Collide




li

JAMA Internal Medicine : Effect of Collaborative Dementia Care on Quality of Life, Caregiver Well-being, and Health Care Use

Interview with Katherine L. Possin, PhD, author of Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial, and Jennifer Tjia, MD, MSCE, FAAHPM, author of A Telephone-Based Dementia Care Management Intervention—Finding the Time to Listen











li

JAMA Cardiology : Utility of 90-Day vs 30-Day Mortality Quality Metrics for Aortic Valve Replacement Outcomes

Interview with Tsuyoshi Kaneko, MD, and Sameer A Hirji, MD, authors of Utility of 90-Day Mortality vs 30-Day Mortality as a Quality Metric for Transcatheter and Surgical Aortic Valve Replacement Outcomes, and Michael J. Mack, MD, author of Ninety-Day Outcome Assessment After Transcatheter and Surgical Aortic Valve Replacement—Is the Juice Worth the Squeeze?









li

JAMA Oncology : HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer

Interview with Nima Sharifi, M.D., author of HSD3B1 Genotype and Clinical Outcomes in Metastatic Castration-Sensitive Prostate Cancer















li

Return money to investors as soon as possible: Sebi to Franklin Templeton

Over Rs 25,000 crore ($3.3 billion) worth of investments belonging to 300,000 investors are currently stuck in the six debt schemes wound up by the fund house




li

Pullback on the higher side likely if Nifty holds 9,100: Anand Rathi

The broader structure of Nifty still looks weak though




li

RIL trades 3% higher on Vista Equity deal; rallies 30% in one month

Jio Platforms has now raised Rs 60,596.37 crore from leading technology investors in less than three weeks.




li

Dr Reddy's hits 52-week high after USFDA issues EIR for Srikakulam facility

The company said, with this, all facilities under warning letter are now determined as Voluntary Action Indicated (VAI)




li

HUL surges 4% after Societe Generale buys 129 million shares via bulk deal

On Thursday, UK-based Glaxo-SmithKline (GSK) offloaded its stake in HUL via block deals.




li

RBL Bank declines 12% from day's high in a firm market post Q4 results

The bank's total revenue jumped 33 per cent YoY to Rs 1,522 crore from Rs 1,148 crore reported in Q4FY19, while its net interest income came in at Rs 1,021 crore, up 38 per cent YoY from Rs 739 crore




li

Hindalco gains 5% after unit Novelis' Q4 results; brokerages maintain 'buy'

Novelis informed that its net income attributable to its common shareholder came in at $63 million for the quarter under review, down 39 per cent year-on-year (YoY




li

Tech-related firms in focus; PPFAS adds Microsoft to portfolio in April

Microsoft is one of the leaders in the cloud computing segment segment, besides Alphabet (Google) and Amazon, making the stock attractive




li

Indian gets 30 months in jail for Little India riot



  • DO NOT USE Indians Abroad
  • World

li

Indian survives 7-day ordeal after falling from Cambodian peak



  • DO NOT USE Indians Abroad
  • World